Daily Archives: September 26, 2016

Head of Saudi Aramco: oil will continue over the coming years to meet the demand for energy, its central position will remain strong

Head of Saudi Aramco: oil will continue over the coming years to meet the demand for energy, its central position will remain strong

Monday 1437/12/24 – 2016/09/26

Dhahran, Dhu-AlHijjah 25, 1437, September 26, 2016, SPA — Head of Saudi Aramco

Foton Super Trucks Launched Globally during IAA 2016

HANNOVER, Germany, Sept. 26, 2016 /PRNewswire/ — At 5:00 PM September 22, 2016 German Time Foton joined hands with members of the “China Intelligent Connected Super Truck Alliance (CICSA)” such as Daimler, Cummins, ZF and Continental AG to deliver Foton

Under patronage of Custodian of the Two Holy Mosques : 31st National Festival for Heritage and Culture to be held on 04/05/1438 AH

Riyadh, 25 Dhu-AlHijjah,1437 AH, 26 September,2016 , SPA — Under the patronage of the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud and his approval to hold the events of the 31st National Festival for Heritage …

Turkish markets hit by Moody's rating downgrade

Turkish markets hit by Moody’s rating downgrade

الاثنين 1437/12/24 هـ الموافق 2016/09/26 م واس

LONDON, Dhu-AlHijjah 25, 1437, September 26, 2016, SPA — Turkey’s stock markets and currency have fallen sharply after the country’s credit rating was downgraded into junk

Saudi Food and Drug Authority bans import of poultry meat and eggs from Togo

Saudi Food and Drug Authority bans import of poultry meat and eggs from Togo

الاثنين 1437/12/24 هـ الموافق 2016/09/26 م واس

Riyadh, 25 Dhu-AlHijjah,1437 AH, 26 September,2016 , SPA — Saudi Food and Drug Authority has imposed a temporary ban

Chinese stocks close below 3,000-mark after period of stability

Beijing, Dhu-AlHijjah 25, 1437, September 26, 2016, SPA — Chinese shares fell below the symbolic 3,000-point
mark on Monday, following months of greater stability and steady
economic growth, according to dpa.
The benchmark Shanghai Composite Index was down 1.76 per …

Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metastatic Melanoma

– 3 Patients with PD-1 Refractory Cutaneous Melanoma are Responders Including One Complete Response (CR) –

– Driven by Increased Prioritization of IMO-2125 Clinical Development, Company Suspends Development of IMO-8400 for B-Cell Lymphomas –

CAMBRIDGE, Mass. and EXTON, Pa., Sept.